Renal oncocytosis: management and clinical outcomes.
OBJECTIVE
Renal oncocytosis is a rare pathological condition in which renal parenchyma is diffusely involved by numerous oncocytic nodules in addition to showing a spectrum of other oncocytic changes. We describe our experience with renal oncocytosis, focusing on management and outcomes.


METHODS
A total of 20 patients with a final pathological diagnosis of renal oncocytosis from July 1995 through June 2009 were included in the analysis. Patient demographics, intraoperative variables and postoperative outcomes are reported.


RESULTS
Median age at nephrectomy was 71 years (IQR 59-75). Of the patients 15 (75%) had bilateral disease. There were 23 operations (9 right side, 14 left side) performed on 20 patients, and of these procedures 13 (57%) were partial nephrectomies and 10 (43%) were radical nephrectomies. Median dominant tumor mass diameter was 4.1 cm (IQR 3-6.4, range 1 to 14.6). The most common dominant tumor histology was hybrid tumor between oncocytoma and chromophobe renal cell carcinoma in 13 of 23 specimens (57%), followed by chromophobe renal cell carcinoma in 6 (26%), oncocytoma in 3 (13%) and conventional renal cell carcinoma in 1 (4%). Ten patients (50%) had preexisting chronic kidney disease before nephrectomy and chronic kidney disease developed in 5 more after surgery. After a median followup of 35 months no patients had metastatic disease.


CONCLUSIONS
Patients with renal oncocytosis usually present with multiple and bilateral renal nodules. Half of the patients had chronic kidney disease at diagnosis and 25% had new onset of chronic kidney disease. No patient had distant metastatic disease during followup. Our management approach is to perform partial nephrectomy when possible and then use careful surveillance of the remaining renal masses.
Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Ari
A
Adamy
William T
WT
Lowrance
David S
DS
Yee
Kian Tai
KT
Chong
Melanie
M
Bernstein
Satish K
SK
Tickoo
Jonathan A
JA
Coleman
Paul
P
Russo
D018249:Adenoma, Oxyphilic / Q000601:surgery; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D011446:Prospective Studies; D016896:Treatment Outcome
Cancer Cell. 2002 Aug;2(2):157-64
12204536
Abdom Imaging. 2009 Mar-Apr;34(2):261-4
18297334
Oncogene. 2001 Aug 23;20(37):5239-42
11526515
Virchows Arch. 2010 Apr;456(4):355-65
20300772
Ann Intern Med. 1999 Mar 16;130(6):461-70
10075613
Int J Urol. 2002 Nov;9(11):646-9
12534911
Clin Lab Med. 2005 Jun;25(2):317-39, vi
15848739
Urology. 1995 Dec;46(6):873-5
7502434
Eur Urol. 2008 May;53(5):1003-11
18061339
Am J Surg Pathol. 2002 Dec;26(12):1542-52
12459621
Pathol Int. 2005 Apr;55(4):210-5
15826248
BJU Int. 2009 May;103(10):1381-4
19154497
Nephrol Dial Transplant. 1999 Sep;14(9):2262-3
10489253
Mod Pathol. 2008 Apr;21(4):498-504
18246052
Arch Pathol Lab Med. 2001 May;125(5):683-5
11300946
J Urol. 2005 May;173(5):1482-6
15821464
Ann Surg Oncol. 2004 Jan;11(1):71-7
14699037
Cancer Genet Cytogenet. 2004 Jul 1;152(1):23-8
15193438
J Med Genet. 2008 Jun;45(6):321-31
18234728
Eur Urol. 2010 Apr;57(4):661-5
19477583
Am J Surg Pathol. 2010 May;34(5):620-6
20305535
J Urol. 1982 Jun;127(6):1179-80
7087030
Am J Surg Pathol. 1999 Sep;23(9):1094-101
10478670
Mayo Clin Proc. 2008 Oct;83(10):1101-6
18828969
Urol Int. 2003;70(3):241-3
12660467
Am J Kidney Dis. 1996 Apr;27(4):579-82
8678070
Clin Nephrol. 2009 Apr;71(4):433-40
19356377